Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 12.05%778.45M | -0.88%1.39B | -3.17%694.74M | -2.99%1.4B | -3.50%717.52M | -22.22%1.44B | -25.89%743.58M | -11.69%1.86B | 10.73%1B | 30.11%2.1B |
| Operating income | 12.05%778.45M | -0.88%1.39B | -3.17%694.74M | -2.99%1.4B | -3.50%717.52M | -22.22%1.44B | -25.89%743.58M | -11.69%1.86B | 10.73%1B | 30.11%2.1B |
| Cost of sales | -11.91%-666.99M | 0.15%-1.2B | 2.85%-596M | 3.51%-1.2B | 3.50%-613.46M | 22.37%-1.24B | 26.81%-635.7M | 11.95%-1.6B | -10.85%-868.61M | -28.83%-1.81B |
| Operating expenses | -11.91%-666.99M | 0.15%-1.2B | 2.85%-596M | 3.51%-1.2B | 3.50%-613.46M | 22.37%-1.24B | 26.81%-635.7M | 11.95%-1.6B | -10.85%-868.61M | -28.83%-1.81B |
| Gross profit | 12.88%111.46M | -5.19%192.73M | -5.11%98.75M | 0.19%203.27M | -3.54%104.06M | -21.28%202.88M | -19.91%107.88M | -10.08%257.73M | 10.02%134.69M | 38.91%286.63M |
| Selling expenses | -2.38%-27.19M | 6.04%-54.12M | 4.61%-26.56M | 7.16%-57.6M | 0.71%-27.85M | -1.91%-62.04M | 12.34%-28.05M | 1.97%-60.88M | -10.87%-31.99M | -8.19%-62.1M |
| Administrative expenses | 1.80%-51.16M | 2.06%-104.51M | 2.02%-52.1M | 8.12%-106.71M | 11.64%-53.17M | 11.20%-116.15M | 16.29%-60.18M | -2.40%-130.79M | -25.50%-71.89M | -9.42%-127.73M |
| Research and development expenses | ---11.76M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | ---- | -56.05%-1.64M | ---- | 30.11%-1.05M | ---- | 23.30%-1.5M | ---4.48M | -789.55%-1.96M | ---- | 80.25%-220K |
| -Other impairment is provision | ---- | -56.05%-1.64M | ---- | 30.11%-1.05M | ---- | 23.30%-1.5M | ---4.48M | -789.55%-1.96M | ---- | 80.25%-220K |
| Special items of operating profit | -108.07%-258K | -36.56%4.47M | 0.50%3.2M | -88.46%7.05M | -82.63%3.18M | 416.75%61.1M | 124.88%18.31M | 115.10%11.82M | 654.68%8.14M | 59.98%5.5M |
| Operating profit | -9.40%21.09M | -17.85%36.93M | -11.22%23.28M | -46.67%44.96M | -21.71%26.22M | 11.01%84.29M | -14.01%33.49M | -25.62%75.93M | 4.24%38.95M | 195.60%102.08M |
| Financing income | 7.40%3.19M | 117.38%6.29M | 223.75%2.97M | 82.47%2.89M | 60.49%918K | 213.44%1.59M | -7.89%572K | -60.09%506K | -36.50%621K | -37.66%1.27M |
| Financing cost | 81.34%-257K | 72.13%-1.78M | 63.31%-1.38M | -1.25%-6.38M | -62.05%-3.75M | -110.38%-6.31M | -23.78%-2.32M | -10.47%-3M | -56.57%-1.87M | 51.22%-2.71M |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | 134.46%3.18M | 92.93%-235K | -6.97%-9.24M | -11.21%-3.32M | -358.77%-8.63M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | -1,118.77%-11.88M | ---2.28M | ---975K | ---- | ---- |
| Earning before tax | -3.41%24.03M | -0.05%41.44M | 6.37%24.88M | -41.49%41.47M | -20.01%23.39M | 12.08%70.87M | -14.95%29.24M | -31.27%63.23M | 0.64%34.38M | 215.90%92M |
| Tax | -24.86%-5.67M | 21.87%-7.14M | -21.86%-4.54M | 15.36%-9.14M | -62.43%-3.72M | -67.60%-10.8M | 52.97%-2.29M | 48.00%-6.44M | -0.72%-4.87M | -681.08%-12.39M |
| After-tax profit from continuing operations | -9.72%18.36M | 6.12%34.3M | 3.43%20.34M | -46.19%32.33M | -27.03%19.67M | 5.79%60.08M | -8.67%26.95M | -28.67%56.79M | 0.62%29.51M | 189.11%79.62M |
| Earning after tax | -9.72%18.36M | 6.12%34.3M | 3.43%20.34M | -46.19%32.33M | -27.03%19.67M | 5.79%60.08M | -8.67%26.95M | -28.67%56.79M | 0.62%29.51M | 189.11%79.62M |
| Minority profit | -200.00%-12K | -134.70%-93K | -133.33%-4K | 1.13%268K | -95.76%12K | -18.21%265K | -29.95%283K | -5.26%324K | 53.61%404K | 304.79%342K |
| Profit attributable to shareholders | -9.68%18.38M | 7.29%34.4M | 3.52%20.34M | -46.40%32.06M | -26.30%19.65M | 5.92%59.81M | -8.38%26.67M | -28.77%56.47M | 0.14%29.1M | 186.14%79.27M |
| Dividend | 0.00%11.39M | ---- | 0.00%11.39M | ---- | -20.00%11.39M | ---- | -16.66%14.24M | ---- | 0.46%17.09M | ---- |
| Basic earnings per share | -9.66%0.0645 | 7.28%0.1208 | 3.48%0.0714 | -46.38%0.1126 | -26.28%0.069 | 5.90%0.21 | -8.41%0.0936 | -29.08%0.1983 | -0.29%0.1022 | 186.18%0.2796 |
| Diluted earnings per share | -9.66%0.0645 | 7.28%0.1208 | 3.48%0.0714 | -46.38%0.1126 | -26.28%0.069 | 5.95%0.21 | -8.33%0.0936 | -29.11%0.1982 | -0.39%0.1021 | 186.18%0.2796 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.